Descovy 200 mg/25 mg (emtricitabine and tenofovir alafenamide) tablet


Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New


From UAE

To United States

in 5-10 days


How It Works

Descovy is a combination medication containing two active ingredients: emtricitabine and tenofovir alafenamide. Emtricitabine and tenofovir alafenamide are both nucleoside reverse transcriptase inhibitors (NRTIs) that work by interfering with the action of an enzyme called reverse transcriptase, which is essential for the replication of the human immunodeficiency virus (HIV). By inhibiting reverse transcriptase, Descovy helps to reduce the amount of HIV in the body and improve immune function.

Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Fatigue
  • Dizziness


  • Descovy is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg in combination with other antiretroviral agents.
  • It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg.


  • Hypersensitivity to emtricitabine, tenofovir alafenamide, or any component of the formulation
  • Co-administration with dofetilide

Price Comparison in Different Countries

Country Price (per unit) References
United States $1,800 GoodRx
United Kingdom ?1,500 NHS
Australia AUD 2,500 PBS Australia
Canada CAD 2,800 CADTH
Germany ?2,000 Apotheken Umschau

Top 5 Global Brands

  1. Pfizer
  2. Roche
  3. Novartis
  4. Merck & Co.
  5. Johnson & Johnson
Shopping Cart